If signed into law, the Main Street Pharmacy Access Act will not arrive as the sweeping, all-encompassing provider-status bill some in the pharmacy profession had envisioned. Experts explain, however, ...
Vaccination and natural infection both train the immune system, but only one route carries the added risk of long COVID and ...
A high-dose flu vaccine lowered flu- and pneumonia-related hospital stays in patients with chronic lung disease, reinforcing flu and pneumococcal vaccinations. In a review of records assessing ...
COVID-19 vaccine resistance has shifted from acute ideological opposition toward broader apathy, a trend now spilling into ...
Data show that commercially and Medicaid-insured children with chronic or immunocompromising conditions incur 2- to 3-fold higher costs. A retrospective cohort study using the Merative MarketScan ...
Eligibility required diary-confirmed perimenstrual attacks in ≥2 of 3 cycles and excluded chronic migraine and certain aura syndromes, strengthening interpretability for episodic menstrual patterns.
Johnson & Johnson now requires comprehensive pharmacy/medical claims elements to be submitted to its 340B ESP platform, with suspension of all 340B pricing within five business days after repeated ...
AD109 produced statistically significant AHI improvement versus placebo at 26 weeks (treatment difference –4.0 events/hour; ...
Cox-adjusted analyses associated ≥1 year HRT use with reduced all-cause dementia (HR 0.90) and Alzheimer disease (HR 0.84), ...
Vanessa Slowey lays the ground for where AI and automation are impacting pharmacy practice today and discusses what ...
Jesse Goodman, MD, MPH, director of the Center on Medical Product Access, Safety and Stewardship (COMPASS) and attending ...
FDA approved 40-mg and 50-mg BID leniolisib for APDS in children 4–11 years weighing ≥27 kg, representing the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results